Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5888

Lifordi gets new funding from Sanofi as it preps to test ADC in rheumatoid arthritis

$
0
0
For patients with chronic immune diseases, glucocorticoids are a double-edged sword. They can have potent effects quelling the disorders, but serious side effects with long-term use. Now, a small startup based just outside of Boston ...

Viewing all articles
Browse latest Browse all 5888

Trending Articles